DarioHealth

$26.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.37 (-1.37%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell DarioHealth and other stocks, options, and ETFs commission-free!

About DRIO

DarioHealth Corp. Common Stock, also called DarioHealth, is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel. The listed name for DRIO is DarioHealth Corp. Common Stock.

CEO

Erez Raphael

Employees

Headquarters

Caesarea, Tel Aviv

Founded

2011

Market Cap

283.86M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

300.46K

High Today

$27.65

Low Today

$24.10

Open Price

$27.19

Volume

178.16K

52 Week High

$31.85

52 Week Low

$3.02

DRIO Earnings

-$1.57

-$1.05

-$0.52

-$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 16, Pre-Market